BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28101225)

  • 1. Monocytic myeloid-derived suppressor cells as a potent suppressor of tumor immunity in non-small cell lung cancer.
    Pogoda K; Pyszniak M; Rybojad P; Tabarkiewicz J
    Oncol Lett; 2016 Dec; 12(6):4785-4794. PubMed ID: 28101225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
    Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
    Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
    Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953
    [No Abstract]   [Full Text] [Related]  

  • 4. TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer.
    Gneo L; Rizkalla N; Hejmadi R; Mussai F; de Santo C; Middleton G
    Cancer Immunol Immunother; 2022 Jul; 71(7):1583-1596. PubMed ID: 34727230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke-Induced Modulation of Myeloid-Derived Suppressor Cells (MDSCs) and IL-10-Producing Regulatory Monocytes.
    Achmus L; Ruhnau J; Grothe S; von Sarnowski B; Bröker BM; Dressel A; Schulze J; Vogelgesang A
    Front Neurol; 2020; 11():577971. PubMed ID: 33329318
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.
    Adamo A; Frusteri C; Pilotto S; Caligola S; Belluomini L; Poffe O; Giacobazzi L; Dusi S; Musiu C; Hu Y; Wang T; Rizzini D; Vella A; Canè S; Sartori G; Insolda J; Sposito M; Incani UC; Carbone C; Piro G; Pettinella F; Qi F; Wang D; Sartoris S; De Sanctis F; Scapini P; Dusi S; Cassatella MA; Bria E; Milella M; Bronte V; Ugel S
    Oncoimmunology; 2023; 12(1):2253644. PubMed ID: 37720688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocytic MDSC as a source of immunosuppressive cytokines in chronic lymphocytic leukemia (CLL) microenvironment.
    Kowalska W; Bojarska-Junak A
    Folia Histochem Cytobiol; 2020; 58(1):25-36. PubMed ID: 32227331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
    Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
    Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.
    Lee CR; Lee W; Cho SK; Park SG
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-Derived Suppressor Cells and CD68
    Lv M; Zhuang X; Shao S; Li X; Cheng Y; Wu D; Wang X; Qiao T
    J Immunol Res; 2022; 2022():3621496. PubMed ID: 35928634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients.
    Bergenfelz C; Larsson AM; von Stedingk K; Gruvberger-Saal S; Aaltonen K; Jansson S; Jernström H; Janols H; Wullt M; Bredberg A; Rydén L; Leandersson K
    PLoS One; 2015; 10(5):e0127028. PubMed ID: 25992611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel role of microphthalmia-associated transcription factor in modulating the differentiation and immunosuppressive functions of myeloid-derived suppressor cells.
    Lee A; Park H; Lim S; Lim J; Koh J; Jeon YK; Yang Y; Lee MS; Lim JS
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36627143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer.
    Zhao T; Liu S; Hanna NH; Jalal S; Ding X; Wan J; Yan C; Du H
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36914206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
    Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
    Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cell cytokine secretion as prognostic factor in myelodysplastic syndromes.
    Han D; Tao J; Fu R; Shao Z
    Innate Immun; 2020 Nov; 26(8):703-715. PubMed ID: 33050756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1.
    Okła K; Rajtak A; Czerwonka A; Bobiński M; Wawruszak A; Tarkowski R; Bednarek W; Szumiło J; Kotarski J
    J Transl Med; 2020 Jun; 18(1):220. PubMed ID: 32487171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
    Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
    Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.